NuVasive (NASDAQ: NUVA)
Some price data may be temporarily unavailable.
NuVasive Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NuVasive Company Info
NuVasive develops and markets minimally invasive products and related solutions for spinal surgeries.
News & Analysis
This Revolutionary Medical Device Company Goes to 11
To stand tall against a competitive market, NuVasive depends on a strong spinal platform.
Is NuVasive Stock a Buy?
What should investors think of this leader in the spinal surgery market?
Can Medical Device Stocks Help Rebuild Your Portfolio?
Some of the biggest medical device companies' stocks have dropped to attractive prices due to the current COVID-19 pandemic.
Why NuVasive, Inc. Stock Is Getting Crushed Today
NuVasive's stock is getting unfairly punished by this moody market.
Here's Why NuVasive, Exelixis, and Natus Medical Fell Today
The healthcare companies couldn't sidestep the COVID-19 slump.
Here's Why Emergent Biosolutions, BioMarin, and Nuvasive Fell on Monday
Even healthcare companies can't escape the overall market downturn.
Why NuVasive Stock Skyrocketed 56.1% in 2019
Demand for the company's minimally invasive surgical approach continues to outpace the broader spine surgery market.
Here’s Why NuVasive Jumped 11.3% in October
A solid third quarter had management increasing 2019 guidance.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.